Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
ValiRx
Life Sciences
Clinical efficacy of VAL401
13 Dec 2017
Evgen Pharma
Life Sciences
Funded to the end of Phase II trials
By
Dr Martin Hall
11 Dec 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Advanced Oncotherapy
Life Sciences
Distribution agreement and capital increase
By
Dr Martin Hall
11 Dec 2017
Life Sciences
UK residential REITs: the start of a journey
By
Mike Foster
30 Nov 2017
Redx Pharma
Life Sciences
Streamlined and clean
By
Dr Martin Hall
13 Nov 2017
Alliance Pharma Plc
Life Sciences
Kelo-cote building international sales
By
Dr Martin Hall
17 Oct 2017
Avacta Group plc
Life Sciences
R&D accelerated to advance assets
By
Dr Martin Hall
16 Oct 2017
Tissue Regenix
Life Sciences
Dual revenue stream growth
11 Oct 2017
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
By
Dr Martin Hall
10 Oct 2017
ValiRx
Life Sciences
Progressing all the pipeline
06 Oct 2017
Scancell Holdings
Life Sciences
Preparing for next clinical studies
By
Dr Martin Hall
03 Oct 2017
Prev
1
...
16
17
18
19
20
21
Next